Fig 3. Comparison of backbone structures for immunogenic and non-immunogenic therapeutic antibodies.

(a) 15 immunogenic antibodies. (b) 14 non-immunogenic antibodies. The crystal structures of all the antibodies were obtained from PDB and superimposed to that of omalizumab (tan in Fig 3B).